» Articles » PMID: 38664652

Chronic Meningitis in Adults: a Comparison Between Neurotuberculosis and Neurobrucellosis

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2024 Apr 25
PMID 38664652
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In regions endemic for tuberculosis and brucellosis, distinguishing between tuberculous meningitis (TBM) and brucella meningitis (BM) poses a substantial challenge. This study investigates the clinical and paraclinical characteristics of patients with TBM and BM.

Methods: Adult patients diagnosed with either TBM or BM who were admitted to two referral hospitals between March 2015 and October 2022, were included, and the characteristics of the patients were analyzed.

Results: Seventy patients formed the study group, 28 with TBM and 42 with BM, were included. TBM patients had a 2.06-fold (95% CI: 1.26 to 3.37, P-value: 0.003) higher risk of altered consciousness and a 4.80-fold (95% CI: 1.98 to 11.61, P-value: < 0.001) higher risk of extra-neural involvement as compared to BM patients. Cerebrospinal fluid (CSF) analysis revealed a significantly higher percentage of polymorphonuclear leukocytes (PMN) in TBM compared to BM (Standardized mean difference: 0.69, 95% CI: 0.18 to 1.20, P-value: 0.008). Neuroimaging findings indicated higher risks of hydrocephalus (P-value: 0.002), infarction (P-value: 0.029), and meningeal enhancement (P-value: 0.012) in TBM compared to BM. Moreover, TBM patients had a 67% (95% CI: 21% to 131%, P-value:0.002) longer median length of hospital stay and a significantly higher risk of unfavorable outcomes (Risk ratio: 6.96, 95% CI: 2.65 to 18.26, p < 0.001).

Conclusions: Our study emphasizes that TBM patients displayed increased frequencies of altered consciousness, PMN dominance in CSF, extra-neural involvement, hydrocephalus, meningeal enhancement, and brain infarction. The findings emphasize the diagnostic difficulties and underscore the importance of cautious differentiation between these two conditions to guide appropriate treatment strategies.

Citing Articles

Case report of neurobrucellosis: a rare complication and neuroimaging findings of a common disease.

Zhang Y, Zou X, Liu L Front Immunol. 2025; 15():1449909.

PMID: 39840056 PMC: 11746083. DOI: 10.3389/fimmu.2024.1449909.


Neurobrucellosis: a retrospective cohort of 106 patients.

Arazi F, Haddad M, Sheybani F, Farzadfard M, Rezaeian M Trop Med Health. 2025; 53(1):9.

PMID: 39815371 PMC: 11737133. DOI: 10.1186/s41182-025-00680-1.

References
1.
Aksamit A . Chronic Meningitis. N Engl J Med. 2021; 385(10):930-936. DOI: 10.1056/NEJMra2032996. View

2.
Bourgi K, Fiske C, Sterling T . Tuberculosis Meningitis. Curr Infect Dis Rep. 2017; 19(11):39. DOI: 10.1007/s11908-017-0595-4. View

3.
Erdem H, Ulu-Kilic A, Kilic S, Karahocagil M, Shehata G, Eren-Tulek N . Efficacy and tolerability of antibiotic combinations in neurobrucellosis: results of the Istanbul study. Antimicrob Agents Chemother. 2011; 56(3):1523-8. PMC: 3294949. DOI: 10.1128/AAC.05974-11. View

4.
Ozates M, Kemaloglu S, Gurkan F, Ozkan U, Hosoglu S, Simsek M . CT of the brain in tuberculous meningitis. A review of 289 patients. Acta Radiol. 2000; 41(1):13-7. DOI: 10.1034/j.1600-0455.2000.041001013.x. View

5.
Jennett B, Bond M . Assessment of outcome after severe brain damage. Lancet. 1975; 1(7905):480-4. DOI: 10.1016/s0140-6736(75)92830-5. View